Mail Back Unused Opioids With a Postage Paid Envelope, FDA Mulls

The FDA is considering letting patients mail back unused opioids to keep them out of the hands of people struggling with substance use disorder in the Biden administration’s latest move to fight rising overdoses.

Health providers dispensing opioids in an outpatient setting would be required to provide patients with “mail-back envelopes and education on safe disposal” of unused drugs under a tweak to the Food and Drug Administration’s Opioid Analgesic Risk Evaluation and Mitigation Strategy the agency floated past stakeholders in a Wednesday filing requesting public comments.

That requirement, the FDA said, “could reduce the amount of unused opioid analgesics ...